Expression of pleiotrophin in small cell lung cancer

H Q Wang, J Wang

Article ID: 5764
Vol 29, Issue 1, 2015
DOI: https://doi.org/10.54517/jbrha5764
Received: 8 April 2015; Accepted: 8 April 2015; Available online: 8 April 2015; Issue release: 8 April 2015

Abstract

Pleiotrophin (PTN) is a kind of heparin binding growth factor closely related to tumor progression. This study aimed to discuss the significance of the expression of PTN in benign and malignant lung cancer tissues, especially small cell lung cancer. Lung cancer samples were collected for study and lung tissue samples with benign lesions were taken as controls. The expression of PTN was detected using tissue chip combined with the immunohistochemical method, and the differences of small cell lung cancer with non-small cell lung cancer and benign lesion tissue were compared. It was found that PTN expression was mainly located in the cytoplasm and membrane of cells; PTN expression in the lung cancer group was higher than that in the control group (p < 0.01), and PTN expression in the small cell cancer group was higher than that in the squamous carcinoma group and glandular cancer group (p < 0.05). In addition, PTN expression quantity in patients with lung cancer were in close correlation with TNM staging, pathological type and tumor differentiation degree (p < 0.05). PTN was found to express abnormally high in lung cancer, especially small cell lung cancer tissue. PTN is most likely to be a new tumor marker for diagnosis and prognosis of lung cancer.


Keywords

pleiotrophin;small cell lung cancer,;expression research;tumor marker


References

Supporting Agencies



Copyright (c) 2015 H Q Wang, J Wang




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).